Anaesthetic efficacy of eugenol on Flowerhorn (Amphilophus labiatus × Amphilophus trimaculatus)

Anaesthetic efficacy of eugenol was investigated on Flowerhorn (Amphilophus labiatus × Amphilophus trimaculatus). A total of 104 fish with average weights of 12 ± 2.5, 28 ± 5 and 53 ±5.1 g were subjected to 25–200 mg L^?1 eugenol and behavioural responses as well as induction and recovery times were recorded. Induction and recovery times were significantly affected by eugenol concentration as well as fish weight (P < 0.05). Generally, 49.9–127.3 s after exposure to 50–200 mg L^?1 eugenol, fish reached stage 3 anaesthesia (suitable for general handling). Fish entered stage 4 anaesthesia (suitable for surgery and blood sampling) over 57.3–140.4 s post exposure to such concentrations. Recovery time was 91.7–312 s in all weight classes for all eugenol concentrations. Mortality (23%) was only observed in 12‐g fish when were subjected to 200 mg L^?1 eugenol. This study showed the behavioural response of Flowerhorn to anaesthesia and eugenol efficacy as an anaesthetic in this important ornamental species. The general quadratic equation revealed that concentrations of eugenol and fish size along with their interactive effects have significantly contributed to the model, with concentration recording the highest beta value in all models (β = ?0.809, ?0.818 and ?0.909, P = 0.000). According to the results, minimum eugenol concentration to induce anaesthesia in less than 3 min was 50 mg L^?1.     

Survival and behavioural responses of cool and warm water fish sedated with AQUI‐S®20E (10% eugenol) at high loading densities

This study evaluated the effects of AQUI‐S^®20E (10% eugenol) sedation on the survival and behaviour of yellow perch Perca flavescens (Mitchill) and Nile tilapia Oreochromis niloticus L. held in high loading densities. Fish were held in 0–300 mg L^?1 AQUI‐S^®20E (0–30 mg L^?1 eugenol) for up to 10 h in static tanks. At 17°C, yellow perch held in 200 and 300 mg L^?1 AQUI‐S^®20E were lightly sedated for up to 7 h. Yellow perch at 200 and 300 mg L^?1 AQUI‐S^®20E also had >95% mean survival 7‐days post exposure using loading densities up to 360 g L^?1. Nile tilapia were only sedated for ≤3 h in concentrations up to 300 mg L^?1 at 22°C and had >90% mean survival at loading densities ≤480 g L^?1. Ammonia in tanks increased significantly as loading density increased, but treatment with AQUI–S^®20E did not reduce ammonia accumulation. Results suggest that AQUI–S^®20E was effective to sedate yellow perch and Nile tilapia at high loading densities, but sedation varied with loading density and species.     

丁香酚对高粱醇溶蛋白可食性膜结构及性能的影响

为开发天然的可降解、可食性包装材料,以高粱醇溶蛋白为原料,采用溶液共混的方法制备可食性丁香酚/高粱醇溶蛋白复合膜,分析不同浓度丁香酚对可食性高粱醇溶蛋白膜物理性能及微观结构的影响并探讨其变化机理。结果表明,添加4%丁香酚可优化蛋白膜的机械性能,提升膜的拉伸强度(TS)和断裂伸长率(EAB);添加丁香酚不影响蛋白膜的水蒸气透过系数(WVP),但略微提高了蛋白膜的溶解度;添加4%丁香酚可增加蛋白膜对紫外光和可见光的吸光度值,即增强膜的光阻隔性能。DSC测量显示,添加丁香酚后降低了高粱醇溶蛋白的玻璃态转变温度(Tg),表明丁香酚提高了丁香酚/高粱醇溶蛋白复合膜的延展性;FTIR分析结果表明,添加丁香酚后使得高粱醇溶蛋白二级结构中的α-螺旋、无规则卷曲转变为β-折叠、β-转角,表明丁香酚有助于提高丁香酚/高粱醇溶蛋白复合膜的机械性能;SEM结果显示,4%丁香酚与高粱醇溶蛋白的相容性良好,制备的复合膜截面光滑紧致。本研究结果为可降解、可食性膜新材料的研究及应用推广提供了理论参考。     

阿司匹林丁香酚酯对大鼠的急性毒性研究

试验旨在评价阿司匹林丁香酚酯（aspirin eugenol ester,AEE）对大鼠的急性毒性,了解AEE毒性特点及可能的毒性靶器官,并全面地分析大鼠的致死原因。试验按照改良寇氏法进行,预试验选取50只大鼠,雌雄各半,分为5组,测定绝对致死量（LD₁₀₀）和最大非致死量（LD₀）。根据预试验结果,将80只健康大鼠,雌雄各半,随机平均分为7个药物组（剂量分别为2.62、3.25、4.03、5.00、6.20、7.69和9.53 g/kg）和1个对照组（给予0.5%的羧甲基纤维素钠（CMC-Na）进行正式试验。灌胃给药,观察并记录大鼠给药后的临床症状及体重变化。给药14 d后,统计各剂量组大鼠的死亡时间及总死亡数,并计算AEE的半数致死量（LD₅₀）及其95%可信限。同时对死亡大鼠及时进行剖检,将具有病变的组织用10%的甲醛溶液固定,以进行病理学分析。结果显示,AEE对大鼠口服的LD₅₀是5.95 g/kg,且LD₅₀的95%可信限为5.30~6.68 g/kg。对大鼠的死亡时间进行分析可得出,当口服AEE的剂量大于4.03 g/kg时,其死亡时间主要集中在染毒后的48~96 h内。大鼠染毒后3 d内,体重呈下降趋势,常规饲养第5天开始,大鼠体重可逐渐恢复。病理学检查分析发现,AEE的剂量在5.00 g/kg以上时,对大鼠的肝脏、肾脏和胃肠道有明显损伤。根据外源化学物急性毒性分级（WHO）可知,AEE为实际无毒化合物,AEE对大鼠毒性靶器官主要是肝脏、肾脏和胃肠道。     

Anaesthetic efficacy of eugenol on iridescent shark,Pangasius hypophthalmus (Sauvage, 1878) in different size classes

Anaesthetic efficacy of eugenol was investigated on iridescent shark, Pangasius hypophthalmus. Fish (2, 5, 10 and 20 g) subjected to 20–200 mg L^?1 eugenol and behavioural response as well as induction and recovery times were recorded. Induction and recovery times were significantly affected by eugenol concentration as well as fish weight (P < 0.05). Generally, 27–300 s after exposure to 20–200 mg L^?1 eugenol, iridescent sharks reached stage 3 anaesthesia (suitable for general handling). Fish entered stage 4 anaesthesia (suitable for surgery and blood sampling) over 54–710 s exposure to such concentrations. Recovery time was 109–600 s in all weight classes as well as eugenol concentrations. Mortality (44–100%) was only observed in 2 g fish when subjected to 110–170 mg L^?1 eugenol. This study, for the first time, showed behavioural response of iridescent shark to anaesthesia as well as effectiveness of eugenol as anaesthetic in this important aquaculture‐ornamental species. According to the models obtained in this study, minimum eugenol concentrations to induce anaesthesia over less than 3 min were 53.8–81.5 mg L^?1 in 2–20 g fish. Likewise, maximum eugenol concentrations in which fish recovered over less than 5 min were 65.9–105.8 mg L^?1 in 2–20 g fish.     

Structure–activity relationships of eugenol derivatives against Aedes aegypti (Diptera: Culicidae) larvae

BACKGROUND: Dengue fever is a severe public health problem for several countries. In order to find effective larvicides to aid control programs, the structure‐activity relationships of eugenol derivatives against Aedes aegypti (Diptera: Culicidae) larvae were evaluated. Additionally, the composition and larvicidal activity of Syzygium aromaticum essential oil was assessed. RESULTS: Four compounds representing 99.05% of S. aromaticum essential oil have been identified. The essential oil was active against Ae. aegypti larvae (LC₅₀ = 62.3 and 77.0 ppm, field‐collected and Rockefeller larvae respectively). The larvicidal activity of eugenol, the major compound of the essential oil, was further evaluated (LC₅₀ = 93.3 and 71.9 ppm, field‐collected and Rockefeller larvae respectively). The larvicidal activity and structure‐activity relationships of synthetic derivatives of eugenol were also assessed. The larvicidal activity of the derivatives varied between 62.3 and 1614.9 ppm. Oxidation of eugenol allylic bond to a primary alcohol and removal of the phenolic proton resulted in decreased potency. However, oxidation of the same double bond in 1‐benzoate‐2‐methoxy‐4‐(2‐propen‐1‐yl)‐phenol resulted in increased potency. CONCLUSION: Structural characteristics were identified that may contribute to the understanding of the larvicidal activity of phenylpropanoids. The present approach may help future work in the search for larvicidal compounds. Copyright © 2012 Society of Chemical Industry     

甲基丁香酚与杀虫剂配合使用对橘小实蝇的诱杀效果

通过观察甲基丁香酚(ME)性诱剂与几种杀虫剂配合使用对橘小实蝇的诱杀效果,发现ME与敌敌畏配合使用对橘小实蝇雄成虫的诱杀效果最好;供试5种含量敌敌畏稀释液中,1∶200体积分数的敌敌畏稀释液对橘小实蝇雄成虫的诱杀效果最理想.     

诱捕器内甲基丁香酚浓度对橘小实蝇引诱效果的影响

通过基团贡献法计算了温度对诱捕器内甲基丁香酚浓度的影响,并测定了一定流速下诱芯数目对甲基丁香酚浓度的影响.结果表明:在一定范围(>15.68℃)内,温度越低,诱捕器内需要越多的诱芯数目才能达到最佳引诱浓度,从而对橘小实蝇起到最佳的引诱效果.     

Daily rhythms of cortisol and glucose and the influence of the light/dark cycle on anaesthesia in Nile tilapia (Oreochromis niloticus): Does the timing of anaesthetic administration affect the stress response?

Although daily variations in drug pharmacokinetics have been reported for a variety of teleost species, the influence of this daily variation on the cortisol response following anaesthesia remains poorly understood. To address this, two experiments were performed. The first experiment described the daily patterns of cortisol and glucose secretion in tilapia (Oreochromis niloticus). The second experiment investigated how the timing of anaesthetic administration (specifically at mid‐light [ML] or at mid‐dark [MD]) affects the induction and recovery times and plasma cortisol and glucose levels of juvenile Nile tilapia exposed to benzocaine, clove oil or tricaine methanesulphonate (MS‐222). The results revealed that the effect on the stress response associated with the moment when anaesthesia took place (ML or MD) varied according to the treatment (p < 0.05). Cortisol levels were significantly higher at ML for MS‐222 (ML = 116.23 ± 25.55; MD = 48.25 ± 22.33 ng/dl) (p < 0.05) and clove oil (ML 59.73 ± 14.27; MD 38.26 ± 12.07 ng/dl) (p < 0.05), whereas no significant differences were found between ML and MD cortisol levels for the control treatment (ML = 72.91 ± 18.42; MD = 64.80 ± 10.68 ng/dl) (p > 0.05) or in the benzocaine‐treated group (ML = 38.7 ± 4.90; MD = 38.60 ± 3.69 ng/dl) (p > 0.05). The highest plasma cortisol level in ML was found in the MS‐222‐treated group. All the tested anaesthetics had similar cortisol levels at MD (p > 0.05).